Cooper SG&A Expenses 2010-2024 | COO

Cooper annual/quarterly sg&a expenses history and growth rate from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Cooper sg&a expenses for the quarter ending October 31, 2024 were $0.391B, a 0.98% increase year-over-year.
  • Cooper sg&a expenses for the twelve months ending October 31, 2024 were $1.534B, a 2.16% increase year-over-year.
  • Cooper annual sg&a expenses for 2024 were $1.534B, a 2.16% increase from 2023.
  • Cooper annual sg&a expenses for 2023 were $1.501B, a 11.85% increase from 2022.
  • Cooper annual sg&a expenses for 2022 were $1.342B, a 10.82% increase from 2021.
Cooper Annual SG&A Expenses
(Millions of US $)
2024 $1,534
2023 $1,501
2022 $1,342
2021 $1,211
2020 $993
2019 $996
2018 $973
2017 $799
2016 $723
2015 $713
2014 $683
2013 $611
2012 $565
2011 $513
2010 $433
2009 $392
Cooper Quarterly SG&A Expenses
(Millions of US $)
2024-10-31 $391
2024-07-31 $381
2024-04-30 $380
2024-01-31 $381
2023-10-31 $388
2023-07-31 $375
2023-04-30 $408
2023-01-31 $331
2022-10-31 $358
2022-07-31 $343
2022-04-30 $322
2022-01-31 $319
2021-10-31 $312
2021-07-31 $353
2021-04-30 $286
2021-01-31 $261
2020-10-31 $264
2020-07-31 $233
2020-04-30 $237
2020-01-31 $258
2019-10-31 $250
2019-07-31 $250
2019-04-30 $247
2019-01-31 $250
2018-10-31 $249
2018-07-31 $251
2018-04-30 $248
2018-01-31 $226
2017-10-31 $209
2017-07-31 $209
2017-04-30 $193
2017-01-31 $189
2016-10-31 $189
2016-07-31 $182
2016-04-30 $178
2016-01-31 $174
2015-10-31 $180
2015-07-31 $192
2015-04-30 $168
2015-01-31 $174
2014-10-31 $208
2014-07-31 $161
2014-04-30 $156
2014-01-31 $158
2013-10-31 $157
2013-07-31 $152
2013-04-30 $151
2013-01-31 $151
2012-10-31 $152
2012-07-31 $144
2012-04-30 $137
2012-01-31 $132
2011-10-31 $140
2011-07-31 $134
2011-04-30 $126
2011-01-31 $113
2010-10-31 $110
2010-07-31 $111
2010-04-30 $111
2010-01-31 $101
2009-10-31 $103
2009-07-31 $100
2009-04-30 $94
2009-01-31 $95
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.615B $3.895B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.221B 20.52
Becton Dickinson (BDX) United States $68.842B 18.04
Cardinal Health (CAH) United States $30.559B 16.57
West Pharmaceutical Services (WST) United States $24.359B 49.75
Labcorp (LH) United States $19.953B 16.54
Align Technology (ALGN) United States $16.739B 32.03
Henry Schein (HSIC) United States $9.129B 17.39
Merit Medical Systems (MMSI) United States $5.997B 30.62
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
Patterson (PDCO) United States $2.729B 14.57
CONMED (CNMD) United States $2.091B 17.45
STAAR Surgical (STAA) United States $1.098B 40.53
Lifevantage (LFVN) United States $0.317B 42.18
Pro-Dex (PDEX) United States $0.145B 28.80